HLB Co., Ltd.

Equities

A028300

KR7028300002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
111,200 ^KRW	+1.65%		+4.61%	+119.33%

Apr. 01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI
Mar. 22	HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	MT

HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 15, 2023 at 04:04 am EDT

HLB Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 444.29 million compared to KRW 300.3 million a year ago. Net loss was KRW 19,903.4 million compared to KRW 15,755.07 million a year ago.

Basic loss per share from continuing operations was KRW 161.9048 compared to KRW 135.1442 a year ago. Diluted loss per share from continuing operations was KRW 161.9048 compared to KRW 135.1442 a year ago. Basic loss per share was KRW 161.9048 compared to KRW 140.9524 a year ago.

Latest news about HLB Co., Ltd.

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	Mar. 31	CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	Mar. 22	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	Mar. 21	CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	Mar. 07	CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	Mar. 03	CI
Bank of Canada Holds Rates Steady; ECB Expected -2-	Jan. 25	DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking	Dec. 22	MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	Dec. 22	MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	Nov. 21	MT
Century Sunshine Group’s Auditor Resigns; Successor Named	Nov. 17	MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	Nov. 17	MT
Jinhai International Gets New Auditor	Nov. 14	MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	23-10-04	MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment	23-09-04	MT
5E Resources Appoints New Auditors	23-09-01	MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-10	CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-08	CI
Hong Leong Bank Digital Banking Platforms Grow 22% as of May	23-07-07	MT
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	23-06-20	CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	23-06-20	CI
HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Ban Loong Appoints New Auditor	23-05-01	MT
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI

Chart HLB Co., Ltd.

Duration

Period

More charts

Company Profile

HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and pipes. The Company operates its business through two segments. The Composite Material segment is mainly engaged in the construction and repair of lifeboats, the manufacture and installation of pipes. The Biomedical Device Business segment is mainly engaged in the development of biopharmaceuticals, the manufacture and sale of medical devices.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HLB CO., LTD.	+119.33%	10.38B
ABBOTT LABORATORIES	-3.72%	186B
MEDTRONIC PLC	-2.60%	107B
BECTON, DICKINSON AND COMPANY	-3.79%	67.44B
DEXCOM, INC.	+2.66%	50.03B
CENCORA, INC.	+16.39%	47.81B
HOYA CORPORATION	+4.79%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.38%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+1.52%	25.82B
ZIMMER BIOMET HOLDINGS, INC.	-1.17%	25.01B

Other Medical Equipment, Supplies & Distribution